NCT06243068
Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
Enrolling by Invitation
NAAges 65+InterventionalHealth servicesGeorge Washington UniversityInvestigator-initiated
~3,000 participants
Updated 2026-06-11 on ClinicalTrials.gov
What's tested:Educate and EngageEducate and Engage Plus Kidney Supportive Care Program
At a glance
Recruiting sites
0 of 25 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients choosing Alternative Treatment Plans (ATP)
Measured over Month 4 after enrollment.
Conditions
Where it's being run
25 sites across 9 statesTexas11
Pennsylvania3
Virginia3
Georgia2
West Virginia2
California1
District of Columbia1
Michigan1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 65 years or older
Most recent eGFR \<30 at time of screening AND meets practice site criteria for KDE referral
Treatment naïve (no dialysis or kidney transplant prior to enrollment)
Family member or care partner of Population 1 patient who has chosen active medical care without dialysis and consented to decisional conflict surveys
18+ years old
English or Spanish speaking
Cognitively able to participate in surveys/interviews
Exclusion
The current decrease in eGFR is thought to be due to an acute event.
Education and initiation of shared decision-making process are not yet indicated for the patient, (per practice protocol and/or provider's judgment).
Insufficient decision-making capacity
Non-English and non-Spanish speaking
Treating nephrologist/APP opts patient out (for example, if contraindicated for patient's health)
What this trial measures
- Proportion of patients choosing Alternative Treatment Plans (ATP)Month 4 after enrollment.
Numerator: number of patients choosing an alternative treatment plan. Denominator: enrolled patients with decision-making capacity.